Latest clinical trial News | Page 2

Cutting-edge technology saves Hawthorn father
Chimeric Therapeutics completes placement with shortfall commitments
From melanoma survivor to skin cancer advocate – Nicole’s story
Smart glasses could help people who are blind or vision impaired navigate by sound
New research finds half-cardio, half-strength training reduces cardiovascular disease risks
Combo treatment improves lung cancer outcomes
Controlling inflammation to conquer lung infections
Chatbot to transform brain injury rehab
CAR T cell therapy for T cell lymphoma shows promise in phase I trial
Carina Biotech doses first patient in Phase 1/2a trial of LGR5-Targeted CAR-T cell therapy
Neuren Pharmaceuticals announces top-line results of Phase 2 NNZ-2591 trial
Aggressive colon tumor may be vulnerable to cholesterol therapy
Discontinuing anti-obesity drug tirzepatide leads to weight regain
New treatment for deadly uterine cancer
Cynata Therapeutics secures approval for Phase 2 trial in Turkey
Microba Life Sciences announces results of successful Phase IBD trial
AUSTRALIAN WORLD-FIRST TRIAL OFFERS NEW HOPE FOR TYPE 1 DIABETES?
OncoSil Medical onboards first patient in the PANCOSIL clinical trial
Korean regulator approves Amplia Therapeutics’ pancreatic cancer trial
Baker Institute appoints Lindsay Maxsted as Life Governor
Aegros Releases Top-Line Interim Clinical Trial Results of its COVID-19 Hyperimmune
Research study into medicinal cannabis calling for patients suffering pain of fibromyalgia
Dr Ben Wylie research to develop kinder and less toxic treatments for cancer
Clairvoyant Surpasses 50 Per Cent Randomization in its Phase 2b Psilocybin Therapy Trial for Alcohol Use Disorder
Keen eye on future
Weill Cornell Medicine to open medical research center
Dimerix’s ACTION3 investigational new drug approved in China
Pharmacy prescribing trial will expand to include some skin conditions
Successful clinical trial for re-engineered UQ vaccine
National register to help fight pancreatic cancer
Australian-invented drug technology used for treatment of anxiety disorders significantly reduces stress hormone response: Phase 2a clinical trial results
World first trial of mobile cardiac treatment could save lives
HaemaLogiX Announces Appointment of Damian Clarke-Bruce as Managing Director and CEO
Virtual reality is helping brain injury survivors regain use of their arms and hands
Dietitians call on the Government to recognise the role of diet for mental health and brain health
Monash engineers make discovery that gives babies with hearing impairment new hope
New strategy attacks treatment-resistant lymphomas
Zibotentan/dapagliflozin combination demonstrated significant albuminuria reduction in patients with chronic kidney disease and proteinuria in ZENITH-CKD Phase IIb trial
Opinion piece: Random trials of policy are just what doctor ordered
New hope to treat and reverse osteoarthritis
Groundbreaking gene therapy trial for Hunter syndrome opens
New clue to treat brain cancer
Imugene announces phase 1 clinical trial opens with onCARlytics CD19 virus technology
Positive efficacy result for Immutep’s ‘efti’ in combination with MSD’s pembrolizumab
Ground-breaking research showcased at SALHN’s Research Week
Why low-cost ketamine is still inaccessible to many with severe depression
Dietary supplement modifies gut microbiome
New view of gene therapy